DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ziagen (Abacavir) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ziagen (Abacavir) death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ziagen side effects in 57 year old female

Reported by a physician from United States on 2012-07-30

Patient: 57 year old female

Reactions: Myocardial Infarction, Arrhythmia

Adverse event resulted in: death

Drug(s) suspected as cause:
Ziagen



Possible Ziagen side effects in 81 year old female

Reported by a consumer/non-health professional from United States on 2012-07-18

Patient: 81 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epivir
    Dosage: 150mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-01
    End date: 2012-07-01

Ziagen
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-01
    End date: 2012-07-01

Other drugs received by patient: Diabetes Medication; Heart Medication; Reyataz; Blood Pressure Medication



Possible Ziagen side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09

Patient: 57 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Ziagen



Possible Ziagen side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06

Patient: 57 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Ziagen



Possible Ziagen side effects in 41 year old male

Reported by a physician from Japan on 2012-03-28

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Other drugs received by patient: Retrovir; Viracept; Recombinate; Loperamide HCL; Crixivan; Octocog Alpha; Loperamide HCL; OIF



Possible Ziagen side effects in 41 year old male

Reported by a physician from Japan on 2012-02-20

Patient: 41 year old male

Reactions: Pancreatitis Acute, Death, Hyperlipidaemia, Hyperlactacidaemia, Amylase Increased, Neuropathy Peripheral, Diarrhoea, Lactic Acidosis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zerit
    Dosage: ongoing 01-aug-1995 to 01-mar-1996 and 01-apr-1998 to 08-dec-2000.
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1995-08-01
    End date: 2000-12-08

Videx
    Dosage: ongoing 01/sept/1993 - 01/aug/1994; 01/mar/1996 - 01/oct/1996; and 10/jan/2000 - 08/dec/2000
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 1993-09-01
    End date: 2000-12-08

Efavirenz
    Dosage: therapy interp 12/8/00,restarted 3/9/01,interrupt7/01,+restarted 7/23/01-25sep8(2622 days)
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-10
    End date: 2008-09-25

Ziagen
    Dosage: therapy interrupted from 08-dec-2000 to 05-jun-2001
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-01-24
    End date: 2001-07-06

Somatropin Rdna
    Indication: Weight Decreased
    Start date: 2001-03-19
    End date: 2001-11-12

Norvir
    Dosage: 05jan01 to 04feb01, 05feb01 to 08mar01 and 26sep08 to ongoing.
    Indication: HIV Infection
    Start date: 2001-01-05

Kaletra
    Dosage: 8 caps 9mar-6jul01, restarted 23jul01 stopped 4oct6 reduced to 6 tabs from 05oct6-15sep8 (1900 days)
    Indication: HIV Infection
    Start date: 2001-03-09
    End date: 2008-09-25

Fosamprenavir Calcium
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-08-04

Prezista
    Dosage: tabs
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26

Raltegravir
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2008-09-26

Amprenavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-07-23
    End date: 2005-08-03

Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-02-13
    End date: 2001-05-10

Epivir
    Dosage: therapy interrupted on 09-jan-2000, discontinued on 06-jul-2001.
    Administration route: Oral
    Start date: 1996-10-01
    End date: 2001-07-06

Truvada
    Dosage: 1 df = 1 tablet
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-09-26
    End date: 2009-10-01

Saquinavir Mesylate
    Indication: HIV Infection
    Start date: 2001-01-05
    End date: 2001-03-08

Other drugs received by patient: OIF; Loperamide HCL; Retrovir; Crixivan; Viracept; Recombinate; Loperamide HCL



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14

Patient:

Reactions: Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Epivir
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-03

Patient:

Reactions: Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Epivir
    Indication: Maternal Exposure Timing Unspecified



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-23

Patient:

Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified

Epivir
    Indication: Maternal Exposure Timing Unspecified



Possible Ziagen side effects in 62 year old male

Reported by a consumer/non-health professional from United States on 2012-01-12

Patient: 62 year old male

Reactions: Death

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ziagen

Other drugs received by patient: Combivent; Bactrim; Prilosec; Magnesium; Zithromax; Kaletra; Imodium; Allopurinol



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06

Patient:

Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Epivir
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-06

Patient:

Reactions: Death, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Epivir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Ziagen side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-22

Patient:

Reactions: Death, Premature Rupture of Membranes, Foetal Exposure During Pregnancy, Exomphalos, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Ziagen
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Intelence
    Indication: Maternal Exposure Timing Unspecified

Epivir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017